Nifedipine-suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Henry P.D.
        • Bentley K.I.
        Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.
        J. Clin. Invest. 1981; 68: 68
        • Stender S.
        • Stender I.
        • Nordestgaard B.
        • Kjeldsen K.
        No effect of nifedipine on atherogenesis in cholesterol-fed rabbits.
        Arteriosclerosis. 1984; 4: 389
        • Van Niekerk J.L.M
        • Hendriks Yh.
        • De Boer H.H.M.
        • Van 't Laar A.
        Does nefidipine suppress atherogenesis in WHHL rabbits?.
        Atherosclerosis. 1984; 53: 91
        • Watanabe Y.
        Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) — Incidence and development of atherosclerosis and xanthoma.
        Atherosclerosis. 1980; 36: 261
        • Stein O.
        • Leitersdorf E.
        • Stein Y.
        Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.
        Arteriosclerosis. 1985; 5: 35